Genfit Ownership

GNFT Stock  USD 4.15  0.05  1.22%   
Roughly 100.0 (percent) of Genfit outstanding shares are held by general public with 0.2 pct. by outside corporations.
 
Shares in Circulation  
First Issued
2012-09-30
Previous Quarter
49.8 M
Current Value
49.7 M
Avarage Shares Outstanding
34.1 M
Quarterly Volatility
12.2 M
 
Yuan Drop
 
Covid
Some institutional investors establish a significant position in stocks such as Genfit in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Genfit, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Dividend Paid And Capex Coverage Ratio is likely to drop to 14.06 in 2024. Net Income Applicable To Common Shares is likely to gain to about 81.2 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 28.1 M in 2024.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genfit. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
For more information on how to buy Genfit Stock please use our How to Invest in Genfit guide.

Genfit Stock Ownership Analysis

The book value of the company was currently reported as 1.37. The company recorded a loss per share of 0.62. Genfit had not issued any dividends in recent years. Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. Genfit S.A. was incorporated in 1999 and is headquartered in Loos, France. Genfit SA operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 134 people. To learn more about Genfit call JeanFrancois Mouney at 33 3 20 16 40 00 or check out https://www.genfit.com.
Besides selling stocks to institutional investors, Genfit also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Genfit's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Genfit's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Genfit Quarterly Liabilities And Stockholders Equity

173.34 Million

Genfit Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Genfit is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Genfit backward and forwards among themselves. Genfit's institutional investor refers to the entity that pools money to purchase Genfit's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Optiver Holding B.v.2023-12-31
82.4 K
Millennium Management Llc2024-03-31
29.7 K
Morgan Stanley - Brokerage Accounts2024-03-31
28.5 K
Rhumbline Advisers2024-03-31
678
Qube Research & Technologies2024-03-31
98.0
Susquehanna International Group, Llp2023-12-31
0.0
Advisory Services Network, Llc2024-03-31
0.0
Old Mission Capital Llc2024-03-31
0.0
O'shaughnessy Asset Management Llc2023-12-31
0.0
Tang Capital Management Llc2024-03-31
0.0
Ubs Group Ag2024-03-31
0.0
Note, although Genfit's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Genfit Corporate Filings

6K
17th of June 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
5th of April 2024
Other Reports
ViewVerify
13A
14th of February 2024
An amended filing to the original Schedule 13G
ViewVerify

Pair Trading with Genfit

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Genfit position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genfit will appreciate offsetting losses from the drop in the long position's value.

Moving together with Genfit Stock

  0.84DYAI Dyadic InternationalPairCorr

Moving against Genfit Stock

  0.83INBX Inhibrx Symbol ChangePairCorr
  0.79DNA Ginkgo Bioworks HoldingsPairCorr
  0.69ILMN IlluminaPairCorr
  0.67BMY Bristol Myers SquibbPairCorr
  0.59MNMD Mind MedicinePairCorr
The ability to find closely correlated positions to Genfit could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Genfit when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Genfit - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Genfit to buy it.
The correlation of Genfit is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Genfit moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Genfit moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Genfit can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Genfit Stock Analysis

When running Genfit's price analysis, check to measure Genfit's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genfit is operating at the current time. Most of Genfit's value examination focuses on studying past and present price action to predict the probability of Genfit's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genfit's price. Additionally, you may evaluate how the addition of Genfit to your portfolios can decrease your overall portfolio volatility.